FiatLux Imaging: Max Lyon new CEO
Mr. Lyon has had a successful 25-year career in the medical technology field including experience in both the emerging medical imaging software and internet-based medical services fields.
Mr. Lyon has been CEO/President of six successful medical companies, five of which he co-founded, including BioControl Systems, Bainbridge Sciences (Bard Diagnostics), CG Therapeutics Adeona Pharmaceuticals, NexCura and Confirma.
Mr. Lyon co-founded and led the acquisition of Bainbridge Sciences by C.R. Bard and continued as the President of Bard Diagnostics, and a senior executive team member of C.R. Bard, for four years. He also served as Senior Vice President of Administration at Genetic Systems and was a co-founder and Director of Oncogen, a joint venture of Syntex Corporation and Genetic Systems.
While CEO of Confirma, Mr. Lyon led the development and international commercial launch of the market leading CADstream software-based service for cancer detection using magnetic resonance imaging (MRI). ■